Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.
about
Treatment of Helicobacter pylori infection 2017.Comparison of Helicobacter pylori Eradication Rates of 2-week Levofloxacin Containing Triple Therapy, Levofloxacin Containing Bismuth Quadruple Therapy and Standard Bismuth Quadruple Therapy as a First-line Regimen.Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.Efficacy of two different dosages of levofloxacin in curing Helicobacter pylori infection: A Prospective, Single-Center, randomized clinical trial.
P2860
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of 1st-line bismuth-c ...... open-label, randomized trial.
@en
Efficacy of 1st-line bismuth-c ...... open-label, randomized trial.
@nl
type
label
Efficacy of 1st-line bismuth-c ...... open-label, randomized trial.
@en
Efficacy of 1st-line bismuth-c ...... open-label, randomized trial.
@nl
prefLabel
Efficacy of 1st-line bismuth-c ...... open-label, randomized trial.
@en
Efficacy of 1st-line bismuth-c ...... open-label, randomized trial.
@nl
P2093
P2860
P1433
P1476
Efficacy of 1st-line bismuth-c ...... open-label, randomized trial.
@en
P2093
Guoxin Zhang
Weifeng Zhang
Xiaoying Zhou
P2860
P356
10.1097/MD.0000000000005859
P407
P577
2017-02-01T00:00:00Z